Company Profile

Plakous Therapeutics Inc
Profile last edited on: 9/22/22      CAGE: 7MED4      UEI: EWBAJV2C51K4

Business Identifier: Human biologics company specializing in restorative and regenerative healing
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

755 Highland Oaks Drive Suite 103
Winston-Salem, NC 27103
Location: Single
Congr. District: 06
County: Forsyth

Public Profile

A human biologics company, Plakous Therapeutics is a patient-focused biotherapeutic company specializing in restorative and regenerative healing. Structured around regenerative therapies R&D, the firm is developing a safe and effective therapeutic platform to promote and sustain healing using the placental cytokines and growth factors that orchestrate fetal development and also allow the body to heal itself. The intent is to improve patient outcomes and reduce health care costs. The firm's first product - designated Protego-PDTM - is an orally delivered acellular biotherapeutic developed from post-delivery placentas

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Robert Boyce -- CEO

  Michael Bentley Berger

  Michael Paul Francis -- Chief Scientific Officer

  Seth Tomblyn -- Chief Science Officer

  Scott Washburn -- Founder, President, and Chief Medical Director